One of the most common complaints we hear from our patients when we first meet them to discuss their cancer diagnosis and treatment plan is that there is a lack of reliable, available information about cancer. Evaluating what is or isn’t a credible source of information on the internet is challenging, even for the most experienced of Googlers. We are seeking to fill that gap by providing the public with understandable, reliable information about cancer.
Join us as we talk to healthcare experts at Ochsner about what you need to know should you or a loved one receive a cancer diagnosis.
All content for All In Against Cancer is the property of Ochsner Cancer Institute and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
One of the most common complaints we hear from our patients when we first meet them to discuss their cancer diagnosis and treatment plan is that there is a lack of reliable, available information about cancer. Evaluating what is or isn’t a credible source of information on the internet is challenging, even for the most experienced of Googlers. We are seeking to fill that gap by providing the public with understandable, reliable information about cancer.
Join us as we talk to healthcare experts at Ochsner about what you need to know should you or a loved one receive a cancer diagnosis.
Clinical trials represent the fundamental agents of progress in cancer care. They allow us to move the needle in advancing new therapies and evaluating novel treatment approaches for our patients. Tens of thousands of cancer patients enroll in clinical trials each year across the United States.
In this special episode of the All In Against Cancer podcast, join host Dr. Jon Mizrahi in a discussion with with Ochsner medical oncologist, Dr. Marc Matrana, and oncology nurse practitioner, Erin Pierce, to learn more about the role and types of clinical trials in oncology and discuss the unique clinical trial opportunities at Ochsner. We will also clear up some common misconceptions about trials and touch upon what we envision for the future of clinical research.
All In Against Cancer
One of the most common complaints we hear from our patients when we first meet them to discuss their cancer diagnosis and treatment plan is that there is a lack of reliable, available information about cancer. Evaluating what is or isn’t a credible source of information on the internet is challenging, even for the most experienced of Googlers. We are seeking to fill that gap by providing the public with understandable, reliable information about cancer.
Join us as we talk to healthcare experts at Ochsner about what you need to know should you or a loved one receive a cancer diagnosis.
